Shah Capital pushes for Novavax sale, warns of proxy fight
By Sneha S K and Sriparna Roy (Reuters) -Shah Capital, Novavax’s second-largest shareholder, is pressing the biotech’s board to pursue…
By Sneha S K and Sriparna Roy (Reuters) -Shah Capital, Novavax’s second-largest shareholder, is pressing the biotech’s board to pursue…
Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy…
On May 19, JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of…
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax…